<?xml version="1.0" encoding="utf-8"?>
<feed xmlns="http://www.w3.org/2005/Atom">
<title>Legal Insider Trading Data | Free and Professional Subscription Services | Insider Insights</title>
<link href="http://www.insiderinsights.com/news/company/mnpr" ></link>
<id>urn:uuid:3e33dc15-f2d6-014a-8b65-cdfd70f714d7</id>
<updated>2026-08-03T22:51:32-04:00</updated>
<author>Jonathan Moreland</author>
<subtitle>Profit from legal insider trading. InsiderInsights.com provides free insider trading data tools and resources, and professional grade subscription based real time Form 4 data, analysis and services</subtitle>
<entry>
<title>MNPR: VU QUAN ANH (CFO) Acquired (JB) 1,228 Shares of MONOPAR THERAPEUTICS for $0.00 on 6/30</title>
<link href="http://www.insiderinsights.com/company/mnpr/monopar-therapeutics/id-6437413" ></link>
<id>urn:uuid:39abbd1f-9106-052a-f1e2-7a9582bb30e2</id>
<updated>2026-07-02T19:38:27-04:00</updated>
<summary type="html" ><![CDATA[MONOPAR THERAPEUTICS (MNPR). Recent Price: $108.35. Mkt Cap:725.8mm. 10D Vol: 332,130]]></summary>
</entry>
<entry>
<title>MNPR: VU QUAN ANH (CFO) Disposed (JS) 507 Shares of MONOPAR THERAPEUTICS for $92.59 on 6/30</title>
<link href="http://www.insiderinsights.com/company/mnpr/monopar-therapeutics/id-6437414" ></link>
<id>urn:uuid:3d298dc9-88d4-7914-d46d-9344b6ab7bf0</id>
<updated>2026-07-02T19:38:27-04:00</updated>
<summary type="html" ><![CDATA[MONOPAR THERAPEUTICS (MNPR). Recent Price: $108.35. Mkt Cap:725.8mm. 10D Vol: 332,130]]></summary>
</entry>
<entry>
<title>MNPR: ROBINSON CHANDLER (CEO,DIR) Acquired (JB) 12,873 Shares of MONOPAR THERAPEUTICS for $0.00 on 6/30</title>
<link href="http://www.insiderinsights.com/company/mnpr/monopar-therapeutics/id-6437415" ></link>
<id>urn:uuid:cbac24b6-c8bf-aaeb-5d3d-38cbb57896d5</id>
<updated>2026-07-02T19:38:00-04:00</updated>
<summary type="html" ><![CDATA[MONOPAR THERAPEUTICS (MNPR). Recent Price: $108.35. Mkt Cap:725.8mm. 10D Vol: 332,130]]></summary>
</entry>
<entry>
<title>MNPR: ROBINSON CHANDLER (CEO,DIR) Disposed (JS) 4,084 Shares of MONOPAR THERAPEUTICS for $92.59 on 6/30</title>
<link href="http://www.insiderinsights.com/company/mnpr/monopar-therapeutics/id-6437416" ></link>
<id>urn:uuid:2055d847-a459-dcd2-a03e-faad8cc92a57</id>
<updated>2026-07-02T19:38:00-04:00</updated>
<summary type="html" ><![CDATA[MONOPAR THERAPEUTICS (MNPR). Recent Price: $108.35. Mkt Cap:725.8mm. 10D Vol: 332,130]]></summary>
</entry>
<entry>
<title>MNPR: CITTADINE ANDREW (COO) Acquired (JB) 5,254 Shares of MONOPAR THERAPEUTICS for $0.00 on 6/30</title>
<link href="http://www.insiderinsights.com/company/mnpr/monopar-therapeutics/id-6437421" ></link>
<id>urn:uuid:933df481-ee64-21bc-d275-4c4c1d3a23d3</id>
<updated>2026-07-02T19:37:33-04:00</updated>
<summary type="html" ><![CDATA[MONOPAR THERAPEUTICS (MNPR). Recent Price: $108.35. Mkt Cap:725.8mm. 10D Vol: 332,130]]></summary>
</entry>
<entry>
<title>MNPR: CITTADINE ANDREW (COO) Disposed (JS) 2,309 Shares of MONOPAR THERAPEUTICS for $92.59 on 6/30</title>
<link href="http://www.insiderinsights.com/company/mnpr/monopar-therapeutics/id-6437422" ></link>
<id>urn:uuid:967e73ac-900c-e771-77da-fa22ad7faec0</id>
<updated>2026-07-02T19:37:33-04:00</updated>
<summary type="html" ><![CDATA[MONOPAR THERAPEUTICS (MNPR). Recent Price: $108.35. Mkt Cap:725.8mm. 10D Vol: 332,130]]></summary>
</entry>
<entry>
<title>MNPR: SWEENY NICOLE (DIR) Filed a Form 3, Becoming a Registered Insider at MONOPAR THERAPEUTICS With Initial  Holdings of 0</title>
<link href="http://www.insiderinsights.com/company/mnpr/monopar-therapeutics/id-6434234" ></link>
<id>urn:uuid:64dd821a-bd71-45ea-ea7c-75e79076fa04</id>
<updated>2026-06-30T16:57:32-04:00</updated>
<summary type="html" ><![CDATA[MONOPAR THERAPEUTICS (MNPR). Recent Price: $108.35. Mkt Cap:725.8mm. 10D Vol: 332,130]]></summary>
</entry>
<entry>
<title>MNPR: ROBINSON CHANDLER (CEO,DIR) Acquired (JB) 6,732 Shares of MONOPAR THERAPEUTICS for $0.00 on 3/31</title>
<link href="http://www.insiderinsights.com/company/mnpr/monopar-therapeutics/id-6378574" ></link>
<id>urn:uuid:d8a99a30-e953-355a-0086-c4ae257e0137</id>
<updated>2026-04-02T15:03:36-04:00</updated>
<summary type="html" ><![CDATA[MONOPAR THERAPEUTICS (MNPR). Recent Price: $108.35. Mkt Cap:725.8mm. 10D Vol: 332,130]]></summary>
</entry>
<entry>
<title>MNPR: ROBINSON CHANDLER (CEO,DIR) Disposed (JS) 1,972 Shares of MONOPAR THERAPEUTICS for $54.79 on 3/31</title>
<link href="http://www.insiderinsights.com/company/mnpr/monopar-therapeutics/id-6378575" ></link>
<id>urn:uuid:e06b3590-ad5e-9895-c580-3de37e49884c</id>
<updated>2026-04-02T15:03:36-04:00</updated>
<summary type="html" ><![CDATA[MONOPAR THERAPEUTICS (MNPR). Recent Price: $108.35. Mkt Cap:725.8mm. 10D Vol: 332,130]]></summary>
</entry>
<entry>
<title>MNPR: CITTADINE ANDREW (COO) Acquired (JB) 3,514 Shares of MONOPAR THERAPEUTICS for $0.00 on 3/31</title>
<link href="http://www.insiderinsights.com/company/mnpr/monopar-therapeutics/id-6378577" ></link>
<id>urn:uuid:de38ca68-5f1e-8f38-abe9-b39fe9b56fdb</id>
<updated>2026-04-02T15:03:03-04:00</updated>
<summary type="html" ><![CDATA[MONOPAR THERAPEUTICS (MNPR). Recent Price: $108.35. Mkt Cap:725.8mm. 10D Vol: 332,130]]></summary>
</entry>
</feed>